Ebselen, abandoned as a stroke treatment, has a successful first human trial as scientists aim to repurpose it as a treatment for bipolar disorder.
Ebselen, abandoned as a stroke treatment, has a successful first human trial as scientists aim to repurpose it as a treatment for bipolar disorder.